SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
SEC Accession No. 0001193125-22-201000
Filing Date
2022-07-25
Accepted
2022-07-25 17:27:53
Documents
8

Document Format Files

Seq Description Document Type Size
1 SC 14D-9/A d332086dsc14d9a.htm SC 14D9/A 50481
2 EXHIBIT (A)(5)(J) d332086dex99a5j.htm EX-99.(A)(5)(J) 41973
3 EXHIBIT (A)(5)(K) d332086dex99a5k.htm EX-99.(A)(5)(K) 53332
4 EXHIBIT (A)(5)(L) d332086dex99a5l.htm EX-99.(A)(5)(L) 9602
5 EXHIBIT (E)(14) d332086dex99e14.htm EX-99.(E)(14) 27282
6 EXHIBIT (E)(15) d332086dex99e15.htm EX-99.(E)(15) 12298
7 GRAPHIC g332086g0725104812987.jpg GRAPHIC 5162
8 GRAPHIC g332086g0725134219045.jpg GRAPHIC 5162
  Complete submission text file 0001193125-22-201000.txt   211407
Mailing Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 44 1223 497400
F-star Therapeutics, Inc. (Filed by) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 44 1223 497400
F-star Therapeutics, Inc. (Subject) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A | Act: 34 | File No.: 005-89626 | Film No.: 221104400
SIC: 2834 Pharmaceutical Preparations